dc.contributor.author
Pérez Millan, Agnès
dc.contributor.author
Contador Muñana, José Miguel
dc.contributor.author
Juncà Parella, J.
dc.contributor.author
Bosch, B.
dc.contributor.author
Borrell, L.
dc.contributor.author
Tort Merino, Adrià
dc.contributor.author
Falgàs, N.
dc.contributor.author
Borrego Écija, Sergi
dc.contributor.author
Bargalló Alabart, Núria
dc.contributor.author
Rami González, Lorena
dc.contributor.author
Balasa, M.
dc.contributor.author
Lladó Plarrumaní, Albert
dc.contributor.author
Sánchez Valle, Raquel
dc.contributor.author
Sala Llonch, Roser
dc.date.issued
2024-02-13T11:54:23Z
dc.date.issued
2024-02-13T11:54:23Z
dc.date.issued
2023-01-20
dc.date.issued
2024-02-08T16:12:14Z
dc.identifier
https://hdl.handle.net/2445/207531
dc.description.abstract
Alzheimer's disease (AD) and frontotemporal dementia (FTD) are common causes of dementia with partly overlapping, symptoms and brain signatures. There is a need to establish an accurate diagnosis and to obtain markers for disease tracking. We combined unsupervised and supervised machine learning to discriminate between AD and FTD using brain magnetic resonance imaging (MRI). We included baseline 3T-T1 MRI data from 339 subjects: 99 healthy controls (CTR), 153 AD and 87 FTD patients; and 2-year follow-up data from 114 subjects. We obtained subcortical gray matter volumes and cortical thickness measures using FreeSurfer. We used dimensionality reduction to obtain a single feature that was later used in a support vector machine for classification. Discrimination patterns were obtained with the contribution of each region to the single feature. Our algorithm differentiated CTR versus AD and CTR versus FTD at the cross-sectional level with 83.3% and 82.1% of accuracy. These increased up to 90.0% and 88.0% with longitudinal data. When we studied the classification between AD versus FTD we obtained an accuracy of 63.3% at the cross-sectional level and 75.0% for longitudinal data. The AD versus FTD versus CTR classification has reached an accuracy of 60.7%, and 71.3% for cross-sectional and longitudinal data respectively. Disease discrimination brain maps are in concordance with previous results obtained with classical approaches. By using a single feature, we were capable to classify CTR, AD, and FTD with good accuracy, considering the inherent overlap between diseases. Importantly, the algorithm can be used with cross-sectional and longitudinal data.© 2023 The Authors. Human Brain Mapping published by Wiley Periodicals LLC.
dc.format
application/pdf
dc.publisher
John Wiley and Sons Inc
dc.relation
Reproducció del document publicat a: https://doi.org/10.1002/hbm.26205
dc.relation
Human Brain Mapping, 2023, vol. 44, num. 6, p. 2234-2244
dc.relation
https://doi.org/10.1002/hbm.26205
dc.rights
cc by-nc (c) Pérez Millan, A. et al., 2023
dc.rights
http://creativecommons.org/licenses/by-nc/3.0/es/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
dc.subject
Malaltia d'Alzheimer
dc.subject
Aprenentatge automàtic
dc.subject
Alzheimer's disease
dc.subject
Machine learning
dc.title
Classifying Alzheimer's disease and frontotemporal dementia using machine learning with cross-sectional and longitudinal magnetic resonance imaging data
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion